Literature DB >> 26377870

Effect of diet-derived advanced glycation end products on inflammation.

Nicole J Kellow1, Melinda T Coughlan2.   

Abstract

Advanced glycation end products (AGEs) formed via the Maillard reaction during the thermal processing of food contributes to the flavor, color, and aroma of food. A proportion of food-derived AGEs and their precursors is intestinally absorbed and accumulates within cells and tissues. AGEs have been implicated in the pathogenesis of diabetes-related complications and several chronic diseases via interaction with the receptor for AGEs, which promotes the transcription of genes that control inflammation. The dicarbonyls, highly reactive intermediates of AGE formation, are also generated during food processing and may incite inflammatory responses through 1) the suppression of protective pathways, 2) the incretin axis, 3) the modulation of immune-mediated signaling, and 4) changes in gut microbiota profile and metabolite sensors. In animal models, restriction of dietary AGEs attenuates chronic low-grade inflammation, but current evidence from human studies is less clear. Here, the emerging relationship between excess dietary AGE consumption and inflammation is explored, the utility of dietary AGE restriction as a therapeutic strategy for the attenuation of chronic diseases is discussed, and possible avenues for future investigation are suggested.
© The Author(s) 2015. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Maillard reaction products.; advanced glycation end products; dicarbonyls; diet; gut; inflammation

Mesh:

Substances:

Year:  2015        PMID: 26377870     DOI: 10.1093/nutrit/nuv030

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  34 in total

1.  Systemic activation of NF-κB driven luciferase activity in transgenic mice fed advanced glycation end products modified albumin.

Authors:  Norbert Nass; Kristina Bayreuther; Andreas Simm
Journal:  Glycoconj J       Date:  2017-02-13       Impact factor: 2.916

2.  Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Eur J Nutr       Date:  2017-06-27       Impact factor: 5.614

3.  Perspective: The Paradox in Dietary Advanced Glycation End Products Research-The Source of the Serum and Urinary Advanced Glycation End Products Is the Intestines, Not the Food.

Authors:  Luanne R DeChristopher
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

Review 4.  Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma.

Authors:  Dan-Vinh Nguyen; Angela Linderholm; Angela Haczku; Nicholas Kenyon
Journal:  Pharmacol Ther       Date:  2017-06-22       Impact factor: 12.310

Review 5.  Cellular mechanisms underlying obesity-induced arterial stiffness.

Authors:  Annayya R Aroor; Guanghong Jia; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

Review 6.  The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.

Authors:  Mark A Bryniarski; Fares Hamarneh; Rabi Yacoub
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-25

7.  Bioremediation of a Common Product of Food Processing by a Human Gut Bacterium.

Authors:  Ashley R Wolf; Darryl A Wesener; Jiye Cheng; Alexandra N Houston-Ludlam; Zachary W Beller; Matthew C Hibberd; Richard J Giannone; Samantha L Peters; Robert L Hettich; Semen A Leyn; Dmitry A Rodionov; Andrei L Osterman; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2019-10-01       Impact factor: 21.023

Review 8.  Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists.

Authors:  Dan-Vinh Nguyen; Angela Linderholm; Angela Haczku; Nicholas Kenyon
Journal:  Lancet Respir Med       Date:  2017-03       Impact factor: 30.700

Review 9.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

10.  Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study.

Authors:  Ana-Lucia Mayén; Elom K Aglago; Viktoria Knaze; Reynalda Cordova; Casper G Schalkwijk; Karl-Heinz Wagner; Krasimira Aleksandrova; Veronika Fedirko; Pekka Keski-Rahkonen; Michael F Leitzmann; Verena Katzke; Bernard Srour; Matthias B Schulze; Giovanna Masala; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Bas Bueno-de-Mesquita; Magritt Brustad; Antonio Agudo; María Dolores Chirlaque López; Pilar Amiano; Bodil Ohlsson; Stina Ramne; Dagfinn Aune; Elisabete Weiderpass; Mazda Jenab; Heinz Freisling
Journal:  Int J Cancer       Date:  2021-04-25       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.